1768 related articles for article (PubMed ID: 27619566)
1. CRISPR-Cas9 technology and its application in haematological disorders.
Zhang H; McCarty N
Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic gene editing in haematological disorders with CRISPR/Cas9.
Jensen TI; Axelgaard E; Bak RO
Br J Haematol; 2019 Jun; 185(5):821-835. PubMed ID: 30864164
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
Ma X; Zhu Q; Chen Y; Liu YG
Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
[TBL] [Abstract][Full Text] [Related]
5. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
Jo YI; Suresh B; Kim H; Ramakrishna S
Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
[TBL] [Abstract][Full Text] [Related]
7. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
8. Genome editing using CRISPR/Cas9 to treat hereditary hematological disorders.
Chen Y; Wen R; Yang Z; Chen Z
Gene Ther; 2022 May; 29(5):207-216. PubMed ID: 33750926
[TBL] [Abstract][Full Text] [Related]
9. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
11. [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].
Han Y; Li QW
Yi Chuan; 2016 Jan; 38(1):9-16. PubMed ID: 26787519
[TBL] [Abstract][Full Text] [Related]
12. The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research.
Li Y; Song YH; Liu B; Yu XY
Int J Cardiol; 2017 Jan; 227():191-193. PubMed ID: 27847153
[TBL] [Abstract][Full Text] [Related]
13. Application of genome editing technologies to the study and treatment of hematological disease.
Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J
Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620
[TBL] [Abstract][Full Text] [Related]
14. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
Li W; Ou G
Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
[TBL] [Abstract][Full Text] [Related]
15. Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N; Schwank G
Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 therapeutics for liver diseases.
Aravalli RN; Steer CJ
J Cell Biochem; 2018 Jun; 119(6):4265-4278. PubMed ID: 29266637
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated noncoding RNA editing in human cancers.
Yang J; Meng X; Pan J; Jiang N; Zhou C; Wu Z; Gong Z
RNA Biol; 2018 Jan; 15(1):35-43. PubMed ID: 29028415
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9, the Powerful New Genome-Editing Tool for Putative Therapeutics in Obesity.
Franco-Tormo MJ; Salas-Crisostomo M; Rocha NB; Budde H; Machado S; Murillo-Rodríguez E
J Mol Neurosci; 2018 May; 65(1):10-16. PubMed ID: 29732484
[TBL] [Abstract][Full Text] [Related]
19. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9 therapies in experimental mouse models of cancer.
Estêvão D; Rios Costa N; da Costa RG; Medeiros R
Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]